Clinical Trial Update: A Phase II Clinical Study of AC-201 Tablets in Subjects With Plaque Psoriasis [Phase 2]

View source ↗

Summary

This update covers a Phase II study of AC-201 tablets in subjects with plaque psoriasis, which has completed. The document notes the trial status as COMPLETED.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• AC-201 tablets (AC-201)

Snippet

Sponsor: Accro Bioscience (Suzhou) Limited | Conditions: Plaque Psoriasis | Phase 2 | Status: COMPLETED